Registered entities
Zelluna Immunotherapy AS
Reg. No. 816823862Norway
Zelluna Immunotherapy AS
Reg. No. 0699.741.964Belgium
Innovation
2 patent families — focus: Chemistry & metallurgy; filing pace active. Cited 34 times.
| Year | Filings |
|---|---|
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Social engagement
Social engagement: 7.2K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
5 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 40% |
| Other / undisclosed | 3 | 60% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
1 Jun 2026 · Junior scientist
Based on job postings tracked across public sources.
Recent activity
25 May 2026
Event
Global Forum
15 May 2026
Event
7th Annual TCR-Based Therapies Summit
11 May 2026
Event
ASGCT 2026